Pronóstico del mercado de sistemas de administración de fármacos transdérmicos de Oriente Medio y África hasta 2030 – Análisis regional – por tipo (parches transdérmicos, gel transdérmico, aerosoles transdérmicos y otros), aplicación (enfermedades cardiovasculares, trastornos del sistema nervioso central, tratamiento del dolor, aplicaciones hormonales y otros) Aplicaciones) y Canal de Distribución (Farmacias Hospitalarias, Farmacias Minoristas, Farmacias en Línea y Otros)
Prevalencia creciente de Las enfermedades crónicas refuerzan el mercado de sistemas de administración transdérmica de fármacos en Oriente Medio y África: Las enfermedades cardiovasculares (ECV), como la angina, la aterosclerosis, el pectoral y el infarto agudo de miocardio, se encuentran entre las causas comunes de mortalidad en el mundo. Según la OMS, las enfermedades cardiovasculares son la principal causa de aproximadamente 17,9 millones de muertes cada año en todo el mundo. Hay muchos medicamentos disponibles comercialmente para el tratamiento de las enfermedades cardiovasculares, pero las cápsulas y comprimidos convencionales no pueden controlar eficazmente la enfermedad. Esto subraya la necesidad de nuevos sistemas de administración de fármacos que proporcionen una biodisponibilidad prolongada y una administración dirigida a las áreas afectadas del sistema cardiovascular. Los sistemas de administración transdérmica de fármacos ofrecen muchas ventajas sobre los fármacos administrados por vía oral para tratar enfermedades cardiovasculares. Se aplican parches transdérmicos, que contienen partículas de fármaco, sobre la superficie de la piel. Un parche cardíaco proporciona una plataforma excelente para mejorar el injerto celular. Por ejemplo, un parche cardíaco vascularizado desarrollado recientemente muestra un potencial prometedor para el tratamiento de lesiones cardíacas isquémicas. Los parches transdérmicos de nitroglicerina se usan para prevenir episodios de angina (dolor en el pecho) en personas con enfermedad de las arterias coronarias. Actúan relajando los vasos sanguíneos y reduciendo la tensión en el corazón, reduciendo así la necesidad de oxígeno. Sin embargo, estos parches no pueden usarse para tratar ataques de angina que ya han comenzado.
El parche de rivastigmina se usa para tratar la demencia (pérdida de memoria) asociada con la enfermedad de Alzheimer leve, moderada o grave o la demencia leve a moderada asociada con la enfermedad de Parkinson. La rivastigmina y el donepezilo son inhibidores de la colinesterasa que exhiben una relación dosis-respuesta, y las dosis más altas de los fármacos demuestran una mayor eficacia. Es una molécula pequeña, lipófila e hidrófila que es químicamente adecuada para la administración transdérmica.
La diabetes es una enfermedad crónica potencialmente mortal que no tiene cura especializada. Ambos tipos de diabetes pueden provocar diversos problemas en diferentes partes del cuerpo y aumentar el riesgo general de muerte prematura. Según los informes de la décima edición del Diabetes Atlas de la Federación Internacional de Diabetes (FID), en 2021, en todo el mundo 537 millones de adultos (de 20 a 79 años) eran diabéticos, y es probable que esa cifra alcance los 643 millones en 2030 y los 783 millones en 2045. Insulina exógena Generalmente se administra por vía subcutánea para el control de la diabetes. Sin embargo, la atención reciente se ha centrado en un parche inteligente que administre insulina cuando sea necesario, simplificando la ingesta de insulina y activando acciones específicas.
Por lo tanto, la creciente incidencia de enfermedades crónicas como las enfermedades cardiovasculares, la enfermedad de Alzheimer y la diabetes refuerzan el crecimiento del mercado de sistemas de administración transdérmica de medicamentos.
Resumen del mercado de sistemas de administración transdérmica de medicamentos en Oriente Medio y África
El mercado de sistemas de administración transdérmica de medicamentos en MEA está segmentado en los Emiratos Árabes Unidos, Arabia Saudita, Sudáfrica y el resto de MEA. Se espera que el crecimiento del mercado aumente debido a la alta prevalencia de enfermedades crónicas, el aumento del gasto sanitario y el aumento de las actividades de I+D en toda la región. Además, la creciente demanda de dispositivos médicos tecnológicamente avanzados ayuda a impulsar el crecimiento del mercado durante el período previsto. Según un estudio \"Enfermedades no transmisibles y respuestas del sistema de salud en Arabia Saudita: enfoque en políticas y estrategias. Un estudio cualitativo\", publicado por Health Research Policy and Systems en 2022, las enfermedades no transmisibles (ENT), en particular la diabetes, las ECV y otras enfermedades crónicas. enfermedades, son responsables de una creciente carga económica y de enfermedades en Arabia Saudita. Según las estadísticas del Ministerio de Salud saudita, las enfermedades cardiovasculares representan el 37% de todas las muertes en Arabia Saudita. Según el Fondo de Población de las Naciones Unidas (UNFPA), se espera que Arabia Saudita experimente un aumento cinco veces mayor en el envejecimiento de la población, de 2 millones (5,9%) en 2020 a 10,5 millones en 2050 (23,7%). La población geriátrica es propensa a padecer afecciones de salud como enfermedades cardiovasculares, infecciones pulmonares y diabetes. Según los datos de Carga Global de Enfermedades publicados en 2020, Arabia Saudita tiene una alta prevalencia de enfermedades no transmisibles como accidentes cerebrovasculares, enfermedades cardíacas, enfermedades renales, EPOC y diabetes. Además, las muertes relacionadas con la diabetes aumentaron aproximadamente un 79 %, la enfermedad renal crónica un 41,2 % y los accidentes cerebrovasculares un 27,6 % entre 2009 y 2019. Por lo tanto, la alta prevalencia de las enfermedades mencionadas alimenta la demanda de sistemas de administración transdérmica de medicamentos, impulsando así el mercado. crecimiento.
Arabia Saudita se asoció con instituciones académicas y de investigación del Reino Unido en 2019 para una iniciativa de 1.600 millones de dólares destinada a mejorar las capacidades nacionales de investigación y desarrollo del Reino. En Arabia Saudita, debido a la creciente demanda de servicios de salud, las crecientes iniciativas gubernamentales favorecen una mayor participación del sector privado para su expansión. Por lo tanto, la creciente prevalencia de enfermedades cardiovasculares en la población y el aumento del gasto sanitario en Arabia Saudita desempeñan un papel vital en el crecimiento del mercado de sistemas de administración transdérmica de medicamentos.
Ingresos del mercado del sistema de administración transdérmica de medicamentos de Oriente Medio y África y pronóstico hasta 2030 (millones de dólares estadounidenses)
Segmentación del mercado del sistema de administración transdérmica de medicamentos de Oriente Medio y África
El mercado del sistema de administración transdérmica de medicamentos de Oriente Medio y África está segmentado por tipo, aplicación, canal de distribución y país.
Según el tipo, el mercado de sistemas de administración transdérmica de medicamentos de Oriente Medio y África se segmenta en parches transdérmicos, gel transdérmico, aerosoles transdérmicos y otros. El segmento de gel transdérmico tuvo la mayor participación en el mercado de sistemas de administración transdérmica de medicamentos de Oriente Medio y África en 2022. Los parches transdérmicos se subdividen aún más en parches de fármaco en adhesivo, parches de matriz, parches de membrana de reservorio y parches de vapor.
En términos de aplicación, el mercado de sistemas de administración transdérmica de fármacos de Oriente Medio y África se clasifica en enfermedades cardiovasculares, trastornos del sistema nervioso central, tratamiento del dolor, aplicaciones hormonales y otras aplicaciones. El segmento de manejo del dolor tuvo la mayor participación en el mercado de sistemas de administración transdérmica de medicamentos de Oriente Medio y África en 2022. El manejo del dolor se subsegmenta además en opioides y no opioides. Las aplicaciones hormonales se subdividen aún más en terapia transdérmica de estrógeno y progesterona y reemplazo de testosterona.
Por canal de distribución, el mercado de sistemas de administración transdérmica de medicamentos de Oriente Medio y África está segmentado en farmacias hospitalarias, farmacias minoristas, farmacias en línea y otros. El segmento de farmacias hospitalarias tuvo la mayor participación en el mercado de sistemas de administración transdérmica de medicamentos de Medio Oriente y África en 2022.
Según el país, el mercado de sistemas de administración transdérmica de medicamentos de Medio Oriente y África se clasifica en los Emiratos Árabes Unidos, Arabia Saudita y Sudáfrica. y el resto de Oriente Medio y África. Arabia Saudita dominó el mercado de sistemas de administración transdérmica de medicamentos en Oriente Medio y África en 2022.
Boehringer Ingelheim International GmbH, GSK Plc, Hisamitsu Pharmaceutical Co Inc, Johnson & Johnson, Novartis AG y Viatris Inc son algunas de las empresas líderes que operan en el mercado de sistemas de administración transdérmica de fármacos en Oriente Medio y África.
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Transdermal Drug Delivery System Market - Key Industry Dynamics
4.1 Market Drivers
4.1.1 Increasing Prevalence of Chronic Diseases
4.1.2 Growing Demand for Noninvasive Drug Delivery Devices
4.1.3 High Demand for Self-Administration of Drugs
4.2 Market Restraints
4.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
4.3 Market Opportunities
4.3.1 Advancements in Smart Patches and 3D-Printed Patches
4.4 Future Trends
4.4.1 Strategic Initiatives by Manufacturers
4.5 Impact Analysis
5. Transdermal Drug Delivery System Market - Middle East & Africa Market Analysis
5.1 Middle East & Africa Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 - 2030
6. Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Type
6.1 Overview
6.2 Middle East & Africa Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Transdermal Patches
6.3.1 Overview
6.3.2 Transdermal Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 Drug-in-Adhesive Patches
6.3.2.1.1 Overview
6.3.2.1.2 Drug-in-Adhesive Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.2 Matrix Patches
6.3.2.2.1 Overview
6.3.2.2.2 Matrix Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.3 Reservoir Membrane Patches
6.3.2.3.1 Overview
6.3.2.3.2 Reservoir Membrane Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.4 Vapor Patches
6.3.2.4.1 Overview
6.3.2.4.2 Vapor Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Transdermal Gels
6.4.1 Overview
6.4.2 Transdermal Gels: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Transdermal Sprays
6.5.1 Overview
6.5.2 Transdermal Sprays: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Others
6.6.1 Overview
6.6.2 Others: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Application
7.1 Overview
7.2 Middle East & Africa Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Cardiovascular Diseases
7.3.1 Overview
7.3.2 Cardiovascular Diseases: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Central Nervous System Disorders
7.4.1 Overview
7.4.2 Central Nervous System Disorders: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Pain Management
7.5.1 Overview
7.5.2 Pain Management: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.5.2.1 Opioid
7.5.2.1.1 Overview
7.5.2.1.2 Opioid: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.5.2.2 Non-Opioid
7.5.2.2.1 Overview
7.5.2.2.2 Non-Opioid: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Hormonal Applications
7.6.1 Overview
7.6.2 Hormonal Applications: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.6.2.1 Transdermal Estrogen & Progesterone Therapy
7.6.2.1.1 Overview
7.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.6.2.2 Testosterone Replacement
7.6.2.2.1 Overview
7.6.2.2.2 Testosterone Replacement: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Other Application
7.7.1 Overview
7.7.2 Other Application: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Distribution Channel
8.1 Overview
8.2 Middle East & Africa Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Retail Pharmacies
8.4.1 Overview
8.4.2 Retail Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Online Pharmacies
8.5.1 Overview
8.5.2 Online Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - Country Analysis
9.1 Middle East & Africa Transdermal Drug Delivery System Market
9.1.1 Middle East & Africa Transdermal Drug Delivery System Market, by Country
9.1.1.1 South Africa: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.1.1 Overview
9.1.1.1.2 South Africa: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.1.3 South Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.1.3.1 South Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.1.4 South Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.1.4.1 South Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.1.4.2 South Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.1.5 South Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.2 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.2.1 Overview
9.1.1.2.2 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.2.3 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.2.3.1 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.2.4 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.2.4.1 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.2.4.2 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.2.5 Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.3 UAE: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.1 Overview
9.1.1.3.2 UAE: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.3 UAE: Middle East & Africa Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.3.3.1 UAE: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.3.4 UAE: Middle East & Africa Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.3.4.1 UAE: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.3.4.2 UAE: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.3.5 UAE: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
9.1.1.4 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.4.1 Overview
9.1.1.4.2 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.4.3 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
9.1.1.4.3.1 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
9.1.1.4.4 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
9.1.1.4.4.1 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
9.1.1.4.4.2 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
9.1.1.4.5 Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
10. Transdermal Drug Delivery System Market Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Transdermal Drug Delivery System Market
10.3 Inorganic Growth Strategies
10.3.1 Overview
10.4 Organic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Novartis AG
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Johnson & Johnson
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 GSK Plc
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Viatris Inc
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Boehringer Ingelheim International GmbH
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Hisamitsu Pharmaceutical Co Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
12. Appendix
12.1 About Us
12.2 Glossary of Terms
?
List of Tables
Table 1. Middle East & Africa Transdermal Drug Delivery System Market Segmentation
Table 2. South Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 3. South Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 4. South Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 5. South Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 6. South Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 7. South Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 8. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 9. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 10. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 11. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 12. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 13. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 14. UAE: Middle East & Africa Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 15. UAE: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 16. UAE: Middle East & Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 17. UAE: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 18. UAE: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 19. UAE: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 20. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
Table 21. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
Table 22. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
Table 23. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
Table 24. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
Table 25. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
Table 26. Recent Inorganic Growth Strategies in the Transdermal Drug Delivery System Market
Table 27. Recent Organic Growth Strategies in the Transdermal Drug Delivery System Market
Table 28. Glossary of Terms, Middle East & Africa Transdermal Drug Delivery System Market
?
List of Figures
Figure 1. Middle East & Africa Transdermal Drug Delivery System Market Segmentation, By Country
Figure 2. Middle East & Africa Transdermal Drug Delivery System Market: Key Industry Dynamics
Figure 3. Middle East & Africa Transdermal Drug Delivery System Market: Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Transdermal Drug Delivery System Market Revenue (US$ Mn), 2020 - 2030
Figure 5. Middle East & Africa Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
Figure 6. Transdermal Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Drug-in-Adhesive Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Matrix Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Reservoir Membrane Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Vapor Patches: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Transdermal Gels: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Transdermal Sprays: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Middle East & Africa Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
Figure 15. Cardiovascular Diseases: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Central Nervous System Disorders: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Pain Management: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Opioid: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Non-Opioid: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Hormonal Applications: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Transdermal Estrogen & Progesterone Therapy: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Testosterone Replacement: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Other Application: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Middle East & Africa Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 25. Hospital Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Retail Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Online Pharmacies: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Others: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Middle East & Africa Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
Figure 30. Middle East & Africa Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
Figure 31. South Africa: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 32. Saudi Arabia: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 33. UAE: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 34. Rest of Middle East & Africa: Middle East & Africa Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
Figure 35. Growth Strategies in the Transdermal Drug Delivery System Market
1. Boehringer Ingelheim International GmbH
2. GSK Plc
3. Hisamitsu Pharmaceutical Co Inc
4. Johnson & Johnson
5. Novartis AG
6. Viatris Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Transdermal Drug Delivery System Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Transdermal Drug Delivery System Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.